课题基金 / 基金详情

Translational imaging tools to nondestructively measure nephron mass

Translational imaging tools to nondestructively measure nephron mass
用于无损测量肾单位质量的平移成像工具
批准号:
10325978
负责人:
Kevin M Bennett
金额:
$29.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-07-01 至 2023-06-30

项目摘要

项目成果

Kevin M Bennett的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY This work is aimed to improve outcomes in patients with kidney disease through improved diagnostics. Nephron mass is a measure of the functional capacity of the kidney. Its measurement could be transformative in detecting susceptibility to and progression of kidney diseases. However, no clinical tools or assays currently exist to directly measure nephron mass. We have developed tools using a novel targeted contrast agent (RadioCF) to directly measure nephron mass using positron emission tomography (PET). This technology, RadioCF-PET, has the potential to provide a more accurate assessment of kidney health and aid clinical decisions for patient treatment. RadioCF-PET also has the potential to be used in the assessment and allocation of renal transplants. This proposal will establish the feasibility of RadioCF-PET to measure nephron mass using a human recombinant form of RadioCF (HrRadioCF) to minimize toxicity, control synthesis and demonstrate the potential of this technology for clinical use. We will measure nephron mass in mice in vivo using RadioCF-PET with human recombinant RadioCF. We will perform initial toxicity studies with HrRadioCF to establish the safety of this radiotracer in mice that will inform the safety and efficacy testing in a Phase II proposal. In Phase II, we will perform extensive toxicity studies and characterization of the agent to support an exploratory investigational new drug application. Future application of RadioCF-PET will first focus on the evaluation of donor kidneys before transplant in both live and deceased donors to monitor allograft health during transit, and then will be adapted to monitor graft function after transplantation. Transplant evaluation provides a pathway to in-patient use of this technology as a new screening tool to monitor kidney health. This technology also has the potential to monitor patients at risk for kidney disease, such as patients with diabetes, indicating a large potential market for impact.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mapping single nephron glomerular filtration rate with mechanisms of autoregulation in the kidney using magnetic resonance imaging
  • 批准号:
    10732632
  • 项目类别:
  • 资助金额:
    $7.69万
  • 财政年份:
    2023
  • 负责人:
    Kevin M Bennett
  • 依托单位:
Resting state MRI to map autoregulation of the kidney
  • 批准号:
    10875266
  • 项目类别:
  • 资助金额:
    $14.0万
  • 财政年份:
    2022
  • 负责人:
    Kevin M Bennett
  • 依托单位:
Resting state MRI to map autoregulation of the kidney
  • 批准号:
    10685502
  • 项目类别:
  • 资助金额:
    $19.91万
  • 财政年份:
    2022
  • 负责人:
    Kevin M Bennett
  • 依托单位:
Resting state MRI to map autoregulation of the kidney
  • 批准号:
    10539432
  • 项目类别:
  • 资助金额:
    $26.3万
  • 财政年份:
    2022
  • 负责人:
    Kevin M Bennett
  • 依托单位: